EU orders extra 200 million doses of Pfizer/BioNTech coronavirus vaccine

EPA-EFE/BIONTECH SE / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES HANDOUT EDITORIAL USE ONLY/NO SALES

Facebook

Twitter

Linkedin

WhatsApp

Viber

Email

Print

German drugmaker BioNTech on Wednesday announced that the European Union will buy an additional 200 million doses of its Coronavirus vaccine, that will be delivered in the second quarter of 2021. “This afternoon, I will be signing a second EU Commission contract with BioNTech/Pfizer for up to an additional 300 million COVID-19 vaccine doses,” the bloc’s health chief Stella Kyriakides tweeted on Wednesday. We are continuing to evaluate, together with governments, authorities, and partners at all levels, how we might address an even higher future supply requirement for our vaccines,” said Dr. The new agreement between Pfizer/BioNTech and the European Commission brings total supply to the EU to 500 million doses, with an option for an additional 100 million doses. Britain?s Medicines & Healthcare Products Regulatory Agency (MHRA) granted on 02 December the authorization for emergency use of the Pfizer/BioNTech coronavirus vaccine BNT162b2. He added that along with US drugmaker Pfizer, they have taken additional steps to boost their production capacity in Europe. EPA-EFE/BIONTECH SE / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES HANDOUT EDITORIAL USE ONLY/NO SALES

An undated handout made available by the German pharmaceutical company Biontech shows a hand holding an ampoule with BNT162b2, the mRNA-based vaccine candidate against COVID-19, in Mainz, Germany (reissued 02 December 2020). style=”font-size:40px; line-height: 1.3em; font-weight: 800; padding:7px;”>EU orders extra 200 million doses of Pfizer/BioNTech coronavirus vaccine

By Zoe Didili
Journalist, New Europe

epa08856436 (FILE) – An undated handout made available by the German pharmaceutical company Biontech shows a hand holding an ampoule with BNT162b2, the mRNA-based vaccine candidate against COVID-19, in Mainz, Germany (reissued 02 December 2020). ✅ This afternoon, I will be signing a second @EU_Commission contract with @BioNTech_Group/@pfizer for up to an additional 300 million #COVID19 vaccine doses. “We will initiate production at our Marburg facility this month and have strengthened our manufacturing network with additional partners. Ugur Sahin, the co-founder of BioNTech. This follows up on our 8 January agreement reached with the company.➡️ https://t.co/gZu4eQADJg
— Stella Kyriakides (@SKyriakidesEU) February 17, 2021